Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
This study has been terminated.
Study NCT00080028 Information provided by Pharmacyclics
First Received: March 22, 2004 Last Updated: May 4, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Head and Neck Cancer
Oropharynx Cancer
Larynx Cancer
Hypopharynx Cancer
Additional conditions recognized in this trial
Head and Neck Neoplasms
Hypopharyngeal Neoplasms
Laryngeal Neoplasms
Oropharyngeal Neoplasms
More general conditions related to this trial
Laryngeal Diseases
Neoplasms
Neoplasms by Site
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Pharyngeal Diseases
Pharyngeal Neoplasms
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Stomatognathic Diseases
Interventions listed in this trial
Motexafin Gadolinium Injection
Additional drug interventions recognized in this trial
Motexafin gadolinium
More general drug interventions related to this trial
Antineoplastic Agents
Dermatologic Agents
Pharmacologic Actions
Photosensitizing Agents
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Pharmacyclics
Back to top of Main Content
